NBP
Price:
$3.99
Market Cap:
$3.25B
NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor. The company also has collaborations with Bristol Myers Squibb for the development...[Read more]
Industry
Biotechnology
IPO Date
2020-01-17
Stock Exchange
NASDAQ
Ticker
NBP
According to NovaBridge Biosciences’s latest financial reports and current stock price. The company's current PE Ratio is -7.82. This represents a change of 25.73% compared to the average of -6.22 of the last 4 quarters.
The mean historical PE Ratio of NovaBridge Biosciences over the last ten years is 0.12. The current -7.82 PE Ratio has changed -650606.81% with respect to the historical average. Over the past ten years (40 quarters), NBP's PE Ratio was at its highest in in the September 2020 quarter at 399.78. The PE Ratio was at its lowest in in the June 2021 quarter at -18.48.
Average
0.12
Median
-2.18
Minimum
-15.86
Maximum
44.59
Discovering the peaks and valleys of NovaBridge Biosciences PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 44.59
Minimum Annual Increase = -1407.98%
Minimum Annual PE Ratio = -15.86
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.43 | -44.43% |
| 2023 | -0.77 | -19.33% |
| 2022 | -0.95 | -90.32% |
| 2021 | -9.80 | -121.99% |
| 2020 | 44.59 | -1407.98% |
| 2019 | -3.41 | -72.53% |
| 2018 | -12.41 | -21.76% |
The current PE Ratio of NovaBridge Biosciences (NBP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.71
5-year avg
6.53
10-year avg
0.12
NovaBridge Biosciences’s PE Ratio is greater than Galectin Therapeutics Inc. (-10.84), greater than Design Therapeutics, Inc. (-8.79), greater than DiaMedica Therapeutics Inc. (-12.53), less than Aura Biosciences, Inc. (-3.69), less than Rocket Pharmaceuticals, Inc. (-1.58), less than Annexon, Inc. (-3.56), greater than Alpha Tau Medical Ltd. (-8.51), less than LB Pharmaceuticals Inc Common Stock (-1.08), greater than enGene Holdings Inc. (-9.75), less than Altimmune, Inc. (-5.66),
| Company | PE Ratio | Market cap |
|---|---|---|
| -10.84 | $405.63M | |
| -8.79 | $559.35M | |
| -12.53 | $449.43M | |
| -3.69 | $409.59M | |
| -1.58 | $370.12M | |
| -3.56 | $536.98M | |
| -8.51 | $346.14M | |
| -1.08 | $487.01M | |
| -9.75 | $420.82M | |
| -5.66 | $468.65M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovaBridge Biosciences using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NovaBridge Biosciences or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is NovaBridge Biosciences's PE Ratio?
How is the PE Ratio calculated for NovaBridge Biosciences (NBP)?
What is the highest PE Ratio for NovaBridge Biosciences (NBP)?
What is the 3-year average PE Ratio for NovaBridge Biosciences (NBP)?
What is the 5-year average PE Ratio for NovaBridge Biosciences (NBP)?
How does the current PE Ratio for NovaBridge Biosciences (NBP) compare to its historical average?